Physician profile
Thomas P Meyer
NPI 1063414324
$1,106.39
in general payments reported to CMS, 2019-2025
19 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $204 · 2021: $160 · 2022: $213 · 2023: $159 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $306.42 | 2019-2025 | |
| Shockwave Medical, INC | $149.81 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $94.54 | 2020-2021 | |
| Philips North America LLC | $77.67 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $70.70 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $55.00 | 2021-2022 | |
| Pfizer INC. | $51.74 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.59 | 2022 | |
| Abbott Laboratories | $37.42 | 2021-2025 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $34.23 | 2022-2023 | Eliquis |
| Boston Scientific Corporation | $31.81 | 2023 | Watchman Access System |
| Kestra Medical Technology Services, INC. | $28.79 | 2025 | Assure Wcd |
| Medicomp INC | $28.67 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.20 | 2019 | |
| Genzyme Corporation | $16.74 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.38 | 2019 | |
| Medline Industries Lp | $16.12 | 2022 | |
| Esperion Therapeutics, INC. | $14.45 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.